MetaCap

CapsoVision (CV) vs Outset Medical (OM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CapsoVision (CV) has outperformed Outset Medical (OM) over the past year, gaining 16.8% versus a loss of 34.5%. CapsoVision is the larger company by market cap ($327.6 million vs $53.0 million), about 6.2 times the size. Outset Medical converts more of its revenue into profit, with a net margin of -68.3% versus -186.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CV+16.83%OM-34.50%
+186%+71%-45%
Nov 21, 20251 yearNov 20, 2026
CV+38.86%OM-86.56%
+215%+57%-101%
Jun 30, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CV versus OM key metrics
MetricCVOM
Share price$6.11$2.81
Market cap$327.56M$53.03M
1-day change-3.17%-3.44%
YTD return-42.84%-24.26%
1-year return+16.83%-34.50%
5-year return—-99.61%
EPS (TTM)$-0.42$-3.78
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$13.55M$119.48M
Revenue growth (YoY)+15.29%+5.09%
Net income (latest FY)$-25.32M$-81.65M
Gross margin52.92%39.13%
Operating margin-188.25%-55.83%
Net margin-186.77%-68.34%
52-week high$15.37$6.49
52-week low$4.50$2.77
Distance from 52-week high-60.25%-56.70%
Analyst consensusstrong_buybuy
Avg. price target upside+55.48%+172.95%
Average volume173.59K140.40K
Shares outstanding53.61M18.87M
Employees99310
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CapsoVision is about 6.2 times larger than Outset Medical by market value ($327.56M vs $53.03M).
  • CV has outperformed OM by 51.3 percentage points over the past year.
  • Outset Medical is more profitable, keeping -68.3 cents of every revenue dollar as net income versus -186.8 cents for CapsoVision.
  • CapsoVision grew revenue faster in its latest fiscal year (+15.29% vs +5.09%).

About CapsoVision

CV stock →

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees

About Outset Medical

OM stock →

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees

CV vs OM FAQ

Which is bigger, CapsoVision or Outset Medical?

CapsoVision (CV) is larger, with a market capitalization of $327.56M compared with $53.03M for Outset Medical (OM).

Which stock has performed better over the past year, CV or OM?

CV returned +16.83% over the past 12 months, compared with -34.50% for OM (price return, excluding dividends). Past performance does not predict future results.

Are CapsoVision and Outset Medical in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons